Basic Information
| LncRNA/CircRNA Name | OR3A4 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | osteosarcoma |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot, Luciferase reporter assay etc. |
| Sample | OS tissues and adjacent normal tissues, cell lines (MG-63, SaoS-2, SJSA-1 and G-292) |
| Expression Pattern | up-regulated |
| Function Description | OR3A4 acted as a sponge of miR-1207-5p. Glucose-6-phosphate dehydrogenase (G6PD) was identified as a target of miR-1207-5p. |
| Pubmed ID | 32346295 |
| Year | 2020 |
| Title | LncRNA OR3A4 Regulated the Growth of Osteosarcoma Cells by Modulating the miR-1207-5p/G6PD Signaling. |
External Links
| Links for OR3A4 | GenBank HGNC NONCODE |
| Links for osteosarcoma | OMIM COSMIC |